| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Bifidobacterium adolescentis |
0.032 |
0.5 |
0.016 － 0.5 |
Amoxicillin-clavulanic acid (Augmentin)  |
1544 |
| Bifidobacterium adolescentis |
0.032 |
>256 |
0.016 － >256 |
Clindamycin (Cleocin) |
1544 |
| Bifidobacterium adolescentis |
0.06 |
0.06 |
≤0.03 － 0.25 |
Imipenem |
490 |
| Bifidobacterium adolescentis |
0.06 |
0.5 |
≤0.03 － 1 |
Zosyn |
490 |
| Bifidobacterium adolescentis |
0.125 |
0.5 |
≤0.03 － 0.5 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
490 |
| Bifidobacterium adolescentis |
0.125 |
0.5 |
≤0.03 － 1 |
Ampicillin (Omnipen) |
490 |
| Bifidobacterium adolescentis |
0.125 |
1 |
0.064 － 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
1544 |
| Bifidobacterium adolescentis |
0.125 |
>32 |
0.016 － >32 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1544 |
| Bifidobacterium adolescentis |
0.25 |
0.25 |
0.125 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
490 |
| Bifidobacterium adolescentis |
0.25 |
0.5 |
≤0.03 － 1 |
Daptomycin + 50 μg/ml Ca++ |
490 |
| Bifidobacterium adolescentis |
0.25 |
4 |
0.032 － 16 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
1544 |
| Bifidobacterium adolescentis |
0.5 |
1 |
0.25 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
490 |
| Bifidobacterium adolescentis |
0.5 |
4 |
0.25 － 4 |
Daptomycin (Cubicin) |
490 |
| Bifidobacterium adolescentis |
0.5 |
16 |
0.25 － >32 |
Levofloxacin (Levaquin, Quixin) |
1544 |
| Bifidobacterium adolescentis |
1 |
1 |
0.25 － 2 |
Quinupristin/Dalfopristin (Synercid) |
490 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
≤0.025 － ? |
Norfloxacin (Noroxin) |
963 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
≤0.025 － ? |
Ofloxacin (Floxin) |
963 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
≤0.025 － ? |
Pipemidic acid |
963 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
<=0.03 － ? |
Clindamycin (Cleocin) |
1477 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
0.125 － ? |
Ceftriaxone (Rocephin) |
1477 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
0.25 － ? |
Cefmetazole |
1477 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
0.5 － ? |
DX-619 |
1477 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
0.78 － ? |
Tosufloxacin |
963 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
1 － ? |
Imipenem |
1477 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
1 － ? |
Levofloxacin (Levaquin, Quixin) |
1477 |
| Bifidobacterium adolescentis (ATCC 15703) |
- |
- |
>16 － ? |
Metronidazole (Flagyl) |
1477 |
| Bifidobacterium adolescentis (ATCC 15704 + 120h) |
- |
- |
2.9 － ? |
Nisin A |
741 |
| Bifidobacterium adolescentis (ATCC 15704 + 120h) |
- |
- |
>63 － ? |
Nisin Z |
741 |